|
|
|
| Application Value of Srm-iv System in Diagnosis and Treatment of Superior Semicircular Canal Benign Paroxysmal Positional Vertigo |
| YANG Qiuyun, MENG Nan, WEI Fuyi |
| Guangxi Baise People's Hospital, Guangxi Baise 533000, China |
|
|
|
|
Abstract Objective: To observe the application value of SRM-IV system in the induction test of benign paroxysmal positional vertigo of superior semicircular canal (AC-BPPV). Methods: 110 patients with ac-bppv admitted to Baise people's Hospital from February 2018 to February 2021 were prospectively selected and randomly divided into experimental group (n = 55) and control group (n = 55) by simple random sampling method. The patients in the experimental group were treated with srm-iv diagnosis and treatment system, while the patients in the control group were treated with conventional manipulative reduction. Both groups were treated for 1 week. The total effective rate, cure time, subjective and objective symptoms, improvement of quality of life, occurrence of complications and recurrence rate of the two groups were compared after one week of treatment. Results: The total effective rate of the experimental group (96.36%) was significantly higher than that of the control group (81.82%), the difference was statistically significant( χ 2=11.652,P<0.05). The cure time of the experimental group [(6. 13 1 ± 66) D] was significantly shorter than that in the control group [(6. 99 0 ± 74) D], the difference was statistically significant (t = 5. 443, P< 0. 05). The difference of subjective and objective symptom related scores (UCLA-DQ, MSQ) before and after treatment in the experimental group [(2.46 0.05)] ± 14)] (63. 10 0 ± 59), which was significantly higher than that of the control group [(1. 58 6 ± 28) (49. 22 0 ± 41)]. The difference of quality of life (DHI) score before and after treatment [(36.12 1 ± 33), which was significantly higher than that of the control group [(22. 50 2 ± 10)]. The incidence of complications in the experimental group (3.64%) was significantly lower than that in the control group (18.18%), the difference was statistically significant (P<0.05). There was no significant difference in the recurrence rate between the experimental group (3.64%) and the control group (5.45%) (P>0.05). Conclusion: The SRM-IV diagnosis and treatment system plays an active role in the diagnosis and treatment of benign paroxysmal positional vertigo in the upper semicircular canal. The treatment effect is significant with few complications, safe and reliable, and at the same time, it significantly improves the subjective and objective symptoms and quality of life of patients. It is suitable for clinical practice and application.
|
|
|
|
|
|
[1] Bhattacharyya N,Gubbels SP,Schwartz SR,et al.Clinical practice guideline: benign paroxysmal positional vertigo (update)executive summary[J].Otolaryngol Head Neck Surg,2017,156(3):403~416.
[2] 陈太生,王巍,徐开旭,等.良性阵发性位置性眩晕及其诊断治疗的思考[J].山东大学耳鼻喉眼学报,2019,33(5):1~4.
[3] 白文婷,王雯,庄建华.改良Epley法与传统Epley法治疗后半规管良性阵发性位置性眩晕的疗效比较[J].现代中西医结合杂志,2020,29(3):301~304.
[4] 中华耳鼻咽喉头颈外科杂志编辑委员会,中华医学会耳鼻咽喉头颈外科学分会.良性阵发性位置性眩晕诊断和治疗指南(2017)[J].中华耳鼻咽喉头颈外科杂志,2017,52(3):173~177.
[5] 李潇潇,区永康,唐小武,等.良性阵发性位置性眩晕复发的临床特征分析[J].临床耳鼻咽喉头颈外科杂志,2018,32(11):823~826.
[6] 袁春云,伍大华,谢乐.SR M -IV前庭功能诊疗系统在良性阵发性位置性眩晕中的应用体会[J].国际神经病学神经外科学杂志,2017,44(1):54~56.
[7] 黄炬辉.重复检查对诊断良性阵发性位置性眩晕的重要性和相关临床特点[J].中国医药科学,2017,7(3):194~196.
[8] 杨晓凯.上半规管良性阵发性位置性眩晕诊断试验分析和物理引擎耳石运动观察[J].解剖学报,2020,51(5):699~704. |
|
|
|
2021, Vol. 27 
